Speciality Medicines Ltd Board of Directors
Key Highlights
- Parth B Goyani continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
- Goyani Sumit Babubhai continues to serve as the Whole-time Director in 2024, maintaining the same position as in the previous year.
- Savani Bhaveshkumar Ashokbhai continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Chandresh M Unagar continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Archana Madhav Bhayani continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
Speciality Medicines Ltd
NSE: SPML
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 30 Mar 2026 | 125.9 |
Company Fundamentals for Speciality Medicines Ltd
Market Price of Speciality Medicines Ltd
1M
1Y
3Y
5Y
Monitoring Speciality Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Speciality Medicines Ltd News Hub
BSE SME Speciality Medicines debuts without fireworks
The scrip was listed at Rs 124, matching the initial public offer (IPO) price. The counter hit a hig
Read more
30 Mar 26
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of null
How are members of Speciality Medicines Ltd Board of Directors selected?
Members of the Speciality Medicines Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Speciality Medicines Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Speciality Medicines Ltd Board of Directors?
Shareholders can interact with the Speciality Medicines Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Speciality Medicines Ltd Board of Directors meet?
The Speciality Medicines Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Speciality Medicines Ltd Board of Directors?
The Speciality Medicines Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Speciality Medicines Ltd?
The current Board of Directors at Speciality Medicines Ltd includes Parth B Goyani( Chairman & Managing Director) ,Goyani Sumit Babubhai( Whole-time Director) ,Savani Bhaveshkumar Ashokbhai( Non Executive Director) ,Chandresh M Unagar( Independent Director) ,Archana Madhav Bhayani( Independent Director) . The full list can be found on Speciality Medicines Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
